Medication for heart conditions improves melanoma treatment
07 September, 2023Administration of ranolazine, a drug currently used to treat heart conditions, improves the efficacy of current therapies for melanoma in mouse models of the disease.
Blood cancer drug attacks dormant HIV cells
05 September, 2023An existing blood cancer drug has shown promise in killing 'silent' HIV cells and delaying reinfection, which could lead to a future cure for the disease.
Eppendorf SciVario twin bioreactor control system
01 September, 2023The SciVario twin is a next-generation bioreactor control system suitable for microbial and cell culture applications.
Cancer drug prevents EMT, metastasis and more
29 August, 2023Blocking epithelial–mesenchymal transition (EMT) in tumours reduces their ability to give rise to metastases and sensitises the tumour cells to chemotherapy.
Diabetes drug could promote healthy aging
22 August, 2023Metformin is a first-line medication for type 2 diabetes, with evidence suggesting the drug may promote healthy aging.
Sartorius Biostat STR bioreactor with Repligen XCell ATF technology
21 August, 2023Sartorius and Repligen Corporation have launched an integrated bioreactor system that incorporates Repligen XCell ATF upstream intensification technology into Sartorius's Biostat STR bioreactor.
Moderna opens Melbourne research centre, partners with Monash
17 August, 2023Moderna has opened its Regional Centre for Respiratory Medicines and Tropical Diseases in Melbourne, as well as its new headquarters for Australia, New Zealand, South-East Asia & Oceania.
FDA approves first known pill for postpartum depression
14 August, 2023Zurzuvae (zuranolone) is understood to be the first and only oral medication indicated to treat adults with postpartum depression (PPD).
Molecular Devices 3D biology portfolio
31 July, 2023Molecular Devices' robust portfolio of end-to-end high-throughput solutions, user-friendly AI-powered data analysis and committed 3D biotechnology investments should support users in overcoming all their 3D biology challenges.
Pharmacists develop a cheeky solution for drug delivery
20 July, 2023Researchers have developed a novel oral film that discreetly releases drugs into the bloodstream via the mucosal membrane — the moist, inner lining of the mouth.
FDA approves gout medication to treat heart disease
18 July, 2023Colchicine, a widely available gout medication, has been approved by the FDA to be used in low doses to prevent cardiovascular events in patients with coronary disease.
Medigrowth and Deakin Uni partner on medicinal cannabis centre
13 July, 2023Medigrowth, a fully licensed Australian medicinal cannabis biotech, has announced plans to build a Centre of Excellence in Geelong in partnership with Deakin University.
New generic cancer treatment spares healthy tissue
05 July, 2023Scientists utilised a compound that is designed to emit small amounts of alpha radiation from the inside of cancer cells, thus killing them but sparing healthy tissue.
Wanted: biotech ventures to join Jumar Bioincubator
05 July, 2023Australia's latest biotech incubator is calling for innovative early-stage Australian biotechs to take up residency in its new facility in the Melbourne Biomedical Precinct.
Peptide drug could treat long COVID, prevent reinfection
03 July, 2023A new study shows that the drug prevents inflammation and even repairs damaged lung tissue in preclinical models, making it both a prevention and a treatment.
